Medical network - December 15 national edition 1010 kinds of clinical pathway has been released, clinical pathway can effectively control the medical expense growth? What drug firms marketing practical effect?
▍ whether spirited through medical costs?
Clinical pathway can effectively improve and unified hospitals at all levels of various disease treatment and disposal process, and low level at the base hospital physicians more and training, popularization and normative significance, but its control effect remains to be consideration.
Hospitals at all levels of each path treatment fees is not synchronized, a lot of diseases such confinement broad, itself have different patients, 3 ~ 14 days or 20 days of hospitalization period, treatment costs are difficult to quantify control.
For the composite disease more difficult to be grasped, superposition of several ailments path, repeated examination, ailment rectification, comprehensive control requires effective advocate for medical institutions and in-depth comprehensive standardized management, otherwise difficult to fundamentally eliminate the policy makers. Groped about implementing path around the actual control effect and summary should be improved in all levels of hospital application report the same to be true, scientific analysis and sharing.
Some aspect of charge policy design details.
The same disease, illness weight is differ, and the hospitalization time, medication and therapy, charge can draw a simple.
Around pricing standard, such as medicine and has slashed prices should synchronous adjustment, or charges not prices drop, design and execution of policy requires careful consideration, avoid making standard all products with high prices, the actual drug use was significantly smaller, damage public interests.
Moreover, have been covered in the charging standards and manifests the costs and benefits of medical institutions, medical institutions have no basis and drug companies to carry out the second negotiation also need to consider, to avoid having canceled addition, the medical treatment charge compensation rising at the same time, enterprises still rightfully demand far higher than the size of medicine bonus incentives, original price to sell to patients, became hospital assets and continue to increase public spending and burden, more businesses have closed down.
▍ drug firms, is pleased, is sick?
Drug companies involved, you may need to focus on all the more to all kinds of medication guide part of the path.
I looked through the rough, involves some fairly on drug use, represented by category, objective and neutral; Some directly beyond normal drug law, ignore the hospital grade differences and the difference between urban and rural, give up the categories of products of all kinds of application of mature products, direct call recommended hundreds and thousands of start after generation product, version at the county level.
Individual path even in some drugs for path name directly, to subvert the concept of clinical pathway. As guideline to use antibiotics in some commonly used classical categories of products almost the entire population, while very small class products occupy the precious several places, all is the one thousand joint venture noble medicine, directly to mow down dozens of block, one hundred, clinical application of mature of other products.
Ignore the rule of progressive science and medicine, will only add to drug resistance and unreasonable and excessive, unfair competition between enterprises and the public medical expense rise quickly, cause enterprise products by path and guide for expensive, directly cut off the whole category, monopolized operation.
And disturb the result of the medical system will lead to excessive consumption and excessive sex, as the base instead of medicine expansion after driving the rapid popularization of some basic market Gao Guiji medicine.
Recent Revelations of ding Lin, enough to ponder. Academic and marketing are the introduction of the foreign enterprise, China's foreign companies as a disseminator of advanced ideas, for domestic medical and pharmaceutical academic atmosphere formation, product systematic promotion, physician training has an indelible contribution.
But on the other hand, academic should uphold the scientific, rigorous, realistic position at any time should not be swayed by other factors, experts work should also be included in the compliance management, can avoid the treasure case many experts for charging request another's help to issue the treasure to pay legal compliance against academic position and the facts of the testimony in a similar situation.
▍ then academic scientific and standardized
In promoting rational drug use, effective control, as a model of all kinds of guide should take the lead in compliance, justice, to avoid enterprises into the guide, into the directory, into the path to use all ways, scrambling to spent money, to increase the investment and burden.
How to scientific reference and a guide to perform more test medical institutions of beginner's mind and science literacy. Countries introduced the principles and policies, most enterprise groups should be conducive to industry and the country, the people's interests, an objective and fair. As unscientific price bidding, resulting in a large number of low-priced products from the market, quickly lost, how to avoid all kinds of clinical drug because of the part in the clinical pathway for common use with tendentiousness and kicked out of the market was deeply unfashionable, is also worth attention.
Directly in the path to the mentioned product basic are the star products of the present and future. Not surprisingly, into the path of the product in the future, so the figure in the top 10.
In terms of dealers, concerned about the clinical pathway in the ground around the situation would be a focus in the future. Path is only good for enterprise marketing one of the access conditions, whether normal bid and payment standards, presence of system and strong sales network, whether attaches great importance to the cultivating the products and good faith, two votes can be smoothly solve, whether manufacturers harmony, such as late really determines the products can be celebrity and star that fit or disappeared.
And reform the dazzling after the combination of rising health care costs to effectively control, really really improve public satisfaction and scientific practice should be the inspection all of the gold standard.
Only to return to medical institutions, for the people to the nation of the beginner's mind, the state and public interests can be ensure, pure unroofed the drug companies, and not come at the beginning of our goals and objectives. The professional management position, can be faster and more accurate to find symptoms, for patients, suit the remedy to the case, avoid zhang is ill, li si.
▍ 2017, medicine ok
10 years) tree, to create a classic brand, from product waiting for at the start of market access, also almost spent 5 ~ 10 years, even longer.
Lucky catch as scheduled on health adjustment cycle, not luck to launch a decade, is still waiting for the tickets of health care, the tender process for the recent 3 years is to let new stall and large area due to the ultra low-cost folding wing, only is the waiting time cost and investment have become room with astonishing overhead.
How to speed up the enterprise product market liquidity, reduce enterprise rising operating costs and prepaid cost and rapidly rising medical costs in the fight against people battle is particularly important. To avoid excessive low, upside down cause enterprises to give up the market in great quantities, a large number of layoffs, the impact and influence to the industry, market supply and public safety severely affected.
Everyone has the right to live in the hospital that day, let the system constantly advancing with The Times, open and transparent, scientific and perfect, the benefit of practitioners and the country, the people. Hope all doctors, patients and medical enterprises will be gentle.
Give medicine person with confidence and security, public health and drug quality and safety, we to hold and keep his job. |
